Parexel reaches first milestone in Microsoft alliance, more coming soon

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/Rawpixel)
(Image: Getty/Rawpixel)

Related tags: Clinical trial, Clinical research

Parexel has launched its first offering as part of its alliance with Microsoft, through which the companies are looking to redefine the life sciences industry, says CRO.

The Waltham, MA-based contract research organization (CRO) Parexel announced the partnership in October​ of this year at which time Xavier Flinois, president of Parexel Informatics told us the alliance “is completely transformational​.”

Since announcing the partnership, the companies have been working to develop a roadmap of innovative, patient-centric technologies and cloud-based services to support clinical research and market access for global life science clients, Paul Bidez, vice president of Regulatory and Clinical Solutions for Parexel told us.

The first offering to result from the partnership is the Perceptive Cloud, which the company said combines Parexel’s technology solutions with Microsoft’s intelligent cloud services and investment in global compliance certifications and enterprise-grade security. 

Together we are committed to enhancing the user experience and truly redefining the life sciences industry​,” Bidez explained. “The Perceptive Cloud is only the first step in this effort​.”

The Perceptive Cloud platform aims to automate workflows and provide greater access to data in order to simplify drug development. The platform includes: LIQUENT InSight Regulatory Information Management (RIM), Study Start-Up, DataLabs Electronic Data Capture (EDC), Managed Access Programs, and IMPACT Clinical Trial Management (CTMS).

New offerings will be announced over the coming months, said Bidez.

The explosion of data is rapidly changing many industries, including healthcare​,” he added.

The cloud computing model enables efficiencies through a shared data platform, while addressing the significant privacy, security and compliance challenges that the pharmaceutical industry faces​.”

Related news

Show more

Related products

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Global Clinical Trial Lab Services

Global Clinical Trial Lab Services

Q2 Solutions | 01-Apr-2020 | Product Presentation

As a leading global lab services partner, we provide operational excellence, scientific leadership and innovation through technology. We offer end-to-end...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Related suppliers

Follow us


View more